03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Diltiaz 30mg* : | |
Type | Medicine Non Marketed |
Originator | G |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | C08DB01 |
Apo-Diltiaz 30mg* :
Apo-Diltiaz 30mg* :
Apo-Diltiaz 30mg* :
Apo-Diltiaz 30mg* :
Apo-Diltiaz 30mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Diltiaz 30mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute generalised exanthematous pustulosis (AGEP) | Not known |
ALT increased | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
AST increased | Uncommon |
Asthenia | Common |
Atrioventricular block (AVB) | Common |
Bradycardia | Uncommon |
Bundle branch block | Common |
Congestive heart failure | Not known |
Constipation | Common |
Depression | Not known |
Dermatitis exfoliative | Not known |
Diarrhoea (Diarrhea) | Uncommon |
Dry mouth (Xerostomia) | Rare |
Dyspepsia | Common |
Epigastralgia (Epigastric pain) | Common |
Erythema | Common |
Erythema multiforme | Not known |
Extrapyramidal symptoms | Not known |
First degree atrioventricular block | Common |
Flushing | Common |
Gingival hyperplasia | Not known |
Gynecomastia (Gynaecomastia) | Not known |
Headache | Common |
Hepatic enzyme increased | Uncommon |
Hepatitis | Not known |
Hyperglycaemia | Not known |
Insomnia | Uncommon |
LDH elevated | Uncommon |
Leukocytoclastic vasculitis | Not known |
Lichenoid keratosis | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Malaise | Common |
Mood alteration | Not known |
Nausea | Common |
Nervousness | Uncommon |
Oedema of lower extremities | Very Common |
Orthostatic hypotension | Uncommon |
Palpitations | Common |
Phosphatase alkaline increased | Uncommon |
Photosensitivity reaction | Not known |
Second degree atrioventricular block | Common |
Sinoatrial block | Not known |
Skin rash | Not known |
Stevens-Johnson syndrome | Not known |
Sweating | Not known |
Third degree atrioventricular block | Common |
Thrombocytopenia (Thrombopenia) | Not known |
Urticaria | Rare |
Vasculitides | Not known |
Vertigo | Common |
Vomiting | Uncommon |
Apo-Diltiaz 30mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Diltiaz 30mg* MoH 3823 :
Form | Tablet |
Package Size | Box of 100 |
Strength | 30mg |
Storage Condition | 15-30°C protect from humidity & light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27354 |
Submission date | 01/01/1992 |
Registration Year | 1992 |
Archived Date | 2014 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 100 | |
● Public Price: | 30 QAR | ( 736,740.00 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,3 QAR | ( 0.00 LBP ) |
● Pharmacy Price: | 24.848240908829 QAR | ( 610223.10023903 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 30 | |
● Public Price: | 12.45 SAR | ( 294,318.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,415 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File